Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Gemcabene (CI-1027) on Insulin Sensitivity in Nondiabetic Subjects

NCT02586168 is registered in ClinicalTrials.gov with NeuroBo Pharmaceuticals Inc. as lead sponsor.

NCT NCT02586168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02586168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Gemcabene (CI-1027) on Insulin Sensitivity in Nondiabetic Subjects
Lead sponsor
NeuroBo Pharmaceuticals Inc.
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2001
Completion date
October 31, 2001
Enrollment
53 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

insulin sensitivity